Renal Disease Flashcards
afferent arteriole
delivers the blood
efferent arteriole
blood exists
proximal tubule
SGLT2 inhibitors work here
Loop of Henle
- Na CL ions are reabsorbed back into the blood, water is not. Unless antidiuretic hormone (ADH) is present, water passes through the wall and is reabsorbed. ADH is also known as vasopressin
- loop diuretics inhibit the Na-K pump (less NA is reabsorbed), also cause less Ca reabsorption back into the blood (SE decrease bone density)
Distal convoluted tubules
thiazide diuretics inhibit the Na-Cl pump. increase in Ca reabsorption
collecting duct
potassium sparring diuretics- including aldosterone antagonists (spironolactone, eplerenone),
ultimately decrease Na and increase K
select drugs that cause kidney disease
Aminoglycosides
Amphotericin B
Cisplatin
Cyclosporine
Loop diuretics
NSAIDs
Polymyxins
Radiographic contrast dye
tacrolimus
vancomycin
cockcroft-gault equation
ACE inhibitors and ARBs for albuminuria
prevent kidney disease progression,
RAAS causes efferent arteriolar dilation
by reducing pressure in the glomerulus, decreasing albuminuria, cardio protection
CKD
GFR <60 and/or albuminuria (ACR or AER >=30)
ACE/ARB increase
K, so monitor
metformin and SGLT2 inhibitors
for pt with CKD, type 2 diabetes, and GFR> 30
SGLT2- specifically canagliflozin, dapagliflozin, and empagliflozin- demonstrated reduction in cardo event and CKD progression
key drugs that require dose reduction or interval increase in CKD
anti-infectives
Aminoglycosides (increase dose interval primarily)
Beta-lactam (except antistaphylococcal and ceftriaxone)
Fluconazole
Quinolones (except moxifloacin)
Vancomycin
key drugs that require dose reduction or interval increase in CKD
cardio drugs
LMWHs (enoxaparin)
Rivaroxaban* (for AF)
Apixaban* (for AF)
Dabigatran* (for AF)
key drugs that require dose reduction or interval increase in CKD
GI
H2RAs (famotidine, ranitidine)
Metoclopramide
key drugs that require dose reduction or interval increase in CKD
others
bisphosphonates
lithium